How Virnich was paid
$1.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Other | Total |
|---|---|---|---|---|---|
| Daniel VirnichChief Executive Officer | $475,000 | $212,729 | $1,235,001 | $12,200 | $1,934,930 |
| Yale PodnosChief Medical Officer | $447,000 | $137,625 | $179,080 | $12,200 | $775,905 |
| Robert CarterChief Financial Officer | $390,000 | $106,930 | $225,000 | $12,200 | $734,130 |
What changed and why
- $1.9MDaniel Virnich received total compensation of $1,934,930 in fiscal 2025.
- $1.2MDaniel Virnich received a stock award grant valued at $1,235,001 in 2025.
- $475KBase salaries for Named Executive Officers were $475,000 for the CEO, $447,000 for Dr. Podnos, and $390,000 for Mr. Carter.
- Annual cash bonuses for 2025 were determined based on revenue, gross profit, and Adjusted EBITDA.
- All named executives were granted restricted stock units vesting in four equal annual installments.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.